康华生物 (300841.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(康华生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 990,055,021.87634,439,056.46278,114,028.881,446,724,761.501,054,548,588.74659,770,823.70266,736,074.86
 营业收入(元) 990,055,021.87634,439,056.46278,114,028.881,446,724,761.501,054,548,588.74659,770,823.70266,736,074.86
二、营业总成本(元) 586,246,100.92363,213,245.23166,597,332.57781,124,617.22505,943,058.82297,315,289.77120,171,079.04
 营业成本(元) 63,760,598.9941,120,618.9017,959,359.4993,134,704.1866,816,073.1640,144,538.6015,509,161.83
 研发费用(元) 185,927,273.77105,813,253.7348,657,680.12179,941,306.14127,730,120.1968,190,430.3421,011,414.14
 营业税金及附加(元) 5,903,315.604,480,351.981,133,460.408,232,556.735,734,516.034,102,776.031,122,913.70
 销售费用(元) 270,260,847.60175,106,092.4078,388,151.54428,119,363.11257,514,687.21153,366,126.0668,683,500.63
 管理费用(元) 66,257,126.4140,462,817.6422,181,067.1082,664,803.9357,963,697.2839,595,614.4719,138,952.77
 财务费用(元) -5,863,061.45-3,769,889.42-1,722,386.08-10,968,116.87-9,816,035.05-8,084,195.73-5,294,864.03
  其中:利息费用(元) 3,540,734.102,355,781.161,024,731.413,188,702.972,001,523.99826,906.2666,489.58
  其中:利息收入(元) 9,242,597.765,934,283.212,768,389.4914,255,002.2111,855,065.098,995,634.095,371,739.10
三、其他经营收益
 加:公允价值变动收益(元) 10,943,588.7715,443,223.9213,053,201.9351,894,043.5611,696,838.419,532,804.3012,539,143.60
 加:投资收益(元) ---5,008,029.555,008,029.555,008,029.55-
 资产减值损失(元) 1,293,078.22-465,228.48-183,963.08-8,706,307.15-944,551.59-868,063.43-651,801.07
 信用减值损失(元) -7,275,210.13-10,157,555.88-7,608,956.94-35,373,816.61-20,032,738.53-18,392,091.05-3,518,772.63
 其他收益(元) -244,090.602,075,909.40261,009.407,079,790.486,604,490.483,906,096.811,200,933.40
四、营业利润(元) 408,526,287.21278,122,160.19117,037,987.62685,501,884.11550,937,598.24361,642,310.11156,134,499.12
 加:营业外收入(元) 44,069.4415,427.3410,876.92122,454.07121,921.865,001.491.49
 减:营业外支出(元) 539,070.42242,028.42159,839.951,831,382.431,184,582.481,128,830.38162.45
五、利润总额(元) 408,031,286.23277,895,559.11116,889,024.59683,792,955.75549,874,937.62360,518,481.22156,134,338.16
 减:所得税费用(元) 39,093,195.7629,690,676.4911,698,408.0685,726,739.5866,561,878.2444,841,993.9920,857,091.39
六、净利润(元) 368,938,090.47248,204,882.62105,190,616.53598,066,216.17483,313,059.38315,676,487.23135,277,246.77
(一)按经营持续性分类
  持续经营净利润(元) 368,938,090.47-105,190,616.53598,066,216.17483,313,059.38315,676,487.23135,277,246.77
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 368,938,090.47248,204,882.62105,190,616.53598,066,216.17483,313,059.38315,676,487.23135,277,246.77
 扣除非经常性损益后的净利润(元) 360,264,245.37233,506,207.7394,000,155.42545,133,687.25464,402,832.26300,951,316.75123,597,785.43
七、每股收益
 一、基本每股收益(元) 2.761.860.794.473.612.351.51
 二、稀释每股收益(元) 2.761.860.794.463.612.351.51
九、综合收益总额(元) 368,938,090.47248,204,882.62105,190,616.53598,066,216.17483,313,059.38315,676,487.23135,277,246.77
 归属于母公司所有者的综合收益总额(元) 368,938,090.47248,204,882.62105,190,616.53598,066,216.17483,313,059.38315,676,487.23135,277,246.77
公告日期 2023-10-212023-08-232023-04-252023-03-302022-10-252022-08-232022-04-22
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院